Mkts

Zymeworks Inc.

NASDAQ: ZYME
$25.54+0.51 (+2.04%)
As of Oct 19, 4:00 PM ET

Key statistics

Day range
25.0625.75
52-week range
16.0031.34
Today
Open25.06
Previous close25.54
Volume999.9K
Valuation
Market cap2.02B
P/E ratio—
EPS (TTM)-2.01
Income & risk
Dividend / yield—
Beta1.33
Avg volume740.2K
Discussion

ZYME News

Stories mentioning ZYME from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,4082,51527,61448,72627,11031,03116,00019,243
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(47,118)(44,152)(22,110)(674.00)(25,613)(22,217)(34,205)(42,886)
Interest Income
Interest Expense
Other Expense(18.00)26.00(8.00)51.00(253.00)(37.00)53.00
Pretax Income(46,353)(41,479)(18,266)2,131(22,140)(17,791)(29,624)(37,618)
Tax Provision(2,191)(270.00)1,336(186.00)496.005,715226.0068.00
Net Income (Loss)(44,162)(41,209)(19,602)2,317(22,636)(23,506)(29,850)(37,686)
Earnings Per Share (Basic)(0.59)(0.55)(0.26)0.03(0.30)(0.31)(0.39)(0.49)
Earnings Per Share (Diluted)(0.59)(0.55)(0.26)0.03(0.30)(0.31)(0.39)(0.49)
Weighted Average Shares Outstanding (Basic)74,66975,40575,76875,33775,17175,84776,12976,393
Weighted Average Shares Outstanding (Diluted)74,69575,41375,77577,37875,22675,87976,15776,396

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ZYME

Zymeworks Inc. (NASDAQ: ZYME) is a stock listed on the Nasdaq Stock Market under the ticker symbol ZYME. It last traded at $25.54 (Oct 19, 2026, 4:00 PM ET), up 2.0% on the day. That gives Zymeworks a market capitalisation of $2.0B.

Over the past 52 weeks ZYME has traded between $16.00 and $31.34.

Revenue for the quarter ended Mar 31, 2026 was $2.4M; a net loss of $44.2M. Revenue was down 91.1% from $27.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.4M-$44.2M-1834.0%
Dec 31, 2025$2.5M-$41.2M-1638.5%
Sep 30, 2025$27.6M-$19.6M-71.0%
Jun 30, 2025$48.7M$2.3M4.8%

From Zymeworks’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…